FINWIRES · TerminalLIVE
FINWIRES

European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading

By

-- European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.27% to 1,794.86 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by brewing firm Anheuser-Busch InBev (BUD) and medical device maker EDAP TMS (EDAP), which advanced 9% and 3% respectively. They were followed by telecommunications companies Ericsson (ERIC) and Nokia (NOK), which rose 2.5% and 2.4% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and internet advertising firm Criteo (CRTO), which shed 9.7% and 3.9% respectively. They were followed by biotech firm BioNTech (BNTX) and consumer goods company Unilever (UL), which fell 3.1% and 0.6% respectively.

The gainers from the UK were led by Biodexa Pharmaceuticals (BDRX) and insurance company Prudential (PUK), which climbed 32% and 2.2% respectively. They were followed by education company Pearson (PSO) and mining company BHP Group (BHP) were up 1.8% and 1.5% respectively.

The decliners from the UK and Ireland were led by lender HSBC (HSBC) and Mereo BioPharma (MREO), which fell 5% and 2.1% respectively. They were followed by Lloyds Banking Group (LYG) and software firm Endava (DAVA), which were down 1.9% each.

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE